Changing outcomes for children requiring intensive care following hematopoietic stem cell transplantation

Saraswati Kache1, Irwin K Weiss, Theodore B Moore

  • 1Division of Critical Care, Department of Paediatrics, David Geffen School of Medicin at UCLA, Los Angeles, CA 90095-1752, USA.

Insights

Survival has improved for children requiring intensive care after bone marrow transplant. However, extreme respiratory failure and dialysis remain poor prognostic indicators, necessitating aggressive treatment for improved outcomes.

Area of Science:

  • Pediatric critical care medicine
  • Hematopoietic stem cell transplantation
  • Pediatric oncology

Background:

  • Respiratory failure post-hematopoietic stem cell transplant (HSCT) historically carried a near 100% mortality.
  • Recent trends suggest improving survival rates for these critically ill pediatric patients.

Purpose of the Study:

  • To evaluate survival trends and identify prognostic factors for pediatric patients admitted to the intensive care unit (ICU) following HSCT.
  • To assess the impact of various clinical factors on mortality in this vulnerable population.

Main Methods:

  • Retrospective review of medical records for 183 pediatric patients (<20 years) who underwent bone marrow transplant (BMT) between 1992 and early 2004.
  • Analysis of factors influencing ICU survival, including reason for transplant, need for dialysis, respiratory parameters (PaO2/FiO2 ratio), ventilation strategies, and other clinical variables.

Main Results:

  • ICU survival significantly increased from 18% (1992-1999) to 59% (2000-2004).
  • Among survivors discharged from ICU in the later period, 54% were alive at 100 days post-transplant.
  • Predictors of poor outcome included malignancy as the transplant indication, dialysis, and extreme respiratory failure (PaO2/FiO2 <300). High PEEP and permissive hypercapnia also correlated with higher mortality.

Conclusions:

  • Survival has markedly improved for pediatric patients requiring ICU care post-BMT, including those needing mechanical ventilation.
  • Malignancy, dialysis, and severe respiratory failure remain associated with poor outcomes.
  • Aggressive treatment strategies are warranted for critically ill pediatric HSCT patients given the overall survival improvements.

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...